Josh Yellson

PHD Doctor of Philosophy,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Legal Support Data Science-Bioinformatics Biostatistics Grant Submission

Areas Of Interest

N Acetylglucosamine Receptors Non Invasive Ventilation Biological Warfare Agents Anoci Association Phospholipase A2, Group IID AKBeta Counter, Radiation Lymphoma, Pleomorphic Status Epilepticus, Alcohol Withdrawal Induced Guanine Nucleotide Exchange Factor C3G Angiografin Syndromes, Deafness-Retinitis Pigmentosa RNA-binding protein, IRP-2 beta Keratin Virus, Ebola Progranulocytic Leukemia Viral Packaging Chromosome 16 Romberg Hemi-Facial Atrophy Progressive Aphasia Total Disc Arthroplasties Hydrochloride, Alphaprodine Estomycin Ushers Syndrome Dysplasias, Septooptic Ambroxol Laminectomies Plant Structure Nudivirus Cephalosporin Amido-beta-Lactam Hydrolase Woman's Health Service viannia brazilienses, Leishmania Organism Forms Brachial Paresis Acute Brain Injury Swertia Small Ribosomal Subunit Protein, lac Z

Professional Narrative

Dr. Josh Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 1996
Executive Director, Mayo Clinic 1999

Education

Master of Science in physician assistant, Perelman School of Medicine 2007
Doctor of osteopathic medicine, Weill Medical College 1990

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :